BioHarvest Sciences Announces Strategic Leadership Transition

BioHarvest Sciences Inc. has announced a strategic leadership transition, with Dr. Zaki Rakib assuming the role of Chief Executive Officer. This move aims to accelerate the company's "two-lens strategy" by integrating R&D, Manufacturing, and Operations under the CDMO division. Ilan Sobel, the former CEO, will join the Board of Directors with a focus on the D2C business. Dr. Rakib, a co-founder, brings extensive leadership experience and a deep understanding of the company's technology. The transition is expected to strengthen the company's competitive position, scale manufacturing capabilities, and drive growth in both the CDMO and D2C sectors. The Board of Directors acknowledged Mr. Sobel's significant contributions over the past six years in growing the company from a pre-revenue operation to approximately $35 million in revenue.